Search Results - "Wang, Feng-Rong"

Incidence, Risk Factors, and Impact on Transplant Outcomes of Cytokine Release Syndrome After Infusion of Haploidentical Stem Cells With Anti‐Thymocyte Globulin.

Authors: Zheng, Feng‐Mei Kong, Jun Wang, Jing‐Zhi et al.

Source: Clinical Transplantation. Jul2025, Vol. 39 Issue 7, p1-9. 9p.

Peritransplant lysine methyltransferase 2a–rearranged measurable residual disease dynamics as a prognostic marker in adult acute myeloid leukemia.

Authors: Wang, Lu‐Lu Zhao, Peng Liu, Jing et al.

Source: Cancer (0008543X). Aug2025, Vol. 131 Issue 16, p1-13. 13p.

The outcomes of second haploidentical donor transplantation for graft failure in patients with severe aplastic anaemia.

Authors: Lin, Ming-Hao Wang, Ya-Jun Zhang, Yuan-Yuan et al.

Source: Annals of Hematology. Jun2025, Vol. 104 Issue 6, p3469-3476. 8p.

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation.

Authors: Shen, Meng-Zhu Hong, Shen-Da Lou, Rui et al.

Source: Experimental Hematology & Oncology. 5/3/2022, Vol. 11 Issue 1, p1-10. 10p.

Outcomes and prognostic factors associated with relapse after haploidentical stem cell transplantation for paediatric T‐cell acute lymphoblastic leukaemia.

Authors: Zhao, Chen Xiao, Meng‐Yu Zhang, Feng et al.

Source: British Journal of Haematology. Apr2025, Vol. 206 Issue 4, p1165-1172. 8p.

Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft‐versus‐host disease.

Authors: Han, Ting‐Ting Zhang, Yi‐Ning Sun, Yu‐Qian et al.

Source: Transplant Infectious Disease. Jun2021, Vol. 23 Issue 3, p1-8. 8p.

Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.

Authors: Deng, Dao-Xing Wen, Juan-Juan Cheng, Yi-Fei et al.

Source: BMC Cancer. 3/19/2021, Vol. 21 Issue 1, p1-12. 12p.

The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia.

Authors: Xu, Zheng‐Li Cheng, Yi‐Fei Zhang, Yuan‐Yuan et al.

Source: Clinical Transplantation. Feb2021, Vol. 35 Issue 2, p1-8. 8p.

Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation.

Authors: Wu, Jin He, Yu‐Chen Huang, Qiu‐Sha et al.

Source: British Journal of Haematology. Oct2024, Vol. 205 Issue 4, p1477-1488. 12p.

Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study.

Authors: Chang, Ying-Jun Wang, Yu Xu, Lan-Ping et al.

Source: Journal of Hematology & Oncology. 3/30/2020, Vol. 13 Issue 1, p1-13. 13p.

Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidates.

Authors: Cao, Le-Qing Lv, Meng Xu, Lan-Ping et al.

Source: Scientific Reports. 2/11/2020, Vol. 10 Issue 1, p1-8. 8p.

Outcomes of haploidentical haematopoietic stem cell transplantation for adolescent and young adults with acute myeloid leukaemia.

Authors: Huo, Wen‐Xuan Wen, Qi Zhang, Xiao‐Hui et al.

Source: British Journal of Haematology. Aug2023, Vol. 202 Issue 4, p856-865. 10p.

Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.

Authors: Zhang, Xiao‐hui Liu, Xiao Wang, Qian‐ming et al.

Source: European Journal of Haematology. Feb2018, Vol. 100 Issue 2, p171-181. 11p.

Predicting short‐term and long‐term mortalities from sepsis in patients who receive allogeneic haematopoietic stem cell transplantation.

Authors: Wu, Ye‐Jun Liu, Hui‐Xin Zhu, Xiao‐Lu et al.

Source: British Journal of Haematology. Jul2023, Vol. 202 Issue 2, p344-355. 12p.

Viral encephalitis after haplo-identical hematopoietic stem cell transplantation: Causative viral spectrum, characteristics, and risk factors.

Authors: Zhang, Xiao‐Hui Zhang, Jia‐Min Han, Wei et al.

Source: European Journal of Haematology. May2017, Vol. 98 Issue 5, p450-458. 9p.

Higher dose of CD34+ peripheral blood stem cells is associated with better survival after haploidentical stem cell transplantation in pediatric patients.

Authors: Chen, Yao Xu, Lan‐Ping Liu, Kai‐Yan et al.

Source: Clinical Transplantation. Feb2017, Vol. 31 Issue 2, pn/a-N.PAG. 11p.

Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis.

Authors: Ma, Yan‐Ru Huang, Xiao‐Jun Xu, Zheng‐Li et al.

Source: Clinical Transplantation. Sep2016, Vol. 30 Issue 9, p994-1001. 8p.

Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantation.

Authors: Chang, Ying-Jun Wang, Hong-Tao Xu, Lan-Ping et al.

Source: Leukemia & Lymphoma. Sep2016, Vol. 57 Issue 9, p2133-2139. 7p.

Haploidentical hematopoietic stem cell transplantation for paediatric high-risk T-cell acute lymphoblastic leukaemia.

Authors: Xu, Zheng‐Li Huang, Xiao‐Jun Liu, Kai‐Yan et al.

Source: Pediatric Transplantation. Jun2016, Vol. 20 Issue 4, p572-580. 9p.

High incidence of engraftment syndrome after haploidentical allogeneic stem cell transplantation.

Authors: Chen, Yao Xu, Lan‐Ping Liu, Kai‐Yan et al.

Source: European Journal of Haematology. May2016, Vol. 96 Issue 5, p517-526. 10p.